Robert Michael
Directeur Général chez TOBIRA THERAPEUTICS INC
Fortune : 17 M $ au 30/04/2024
Profil
Robert A. Michael est directeur financier et vice-président exécutif d'AbbVie, Inc. et directeur général de Fremont Holding LLC, directeur général de Tobira Therapeutics, Inc. et président et directeur d'Allergan Plc (qui sont toutes des filiales d'AbbVie, Inc.). M. Michael est également membre du conseil d'administration d'AbbVie Biotherapeutics Ltd. M. Michael a précédemment occupé le poste de contrôleur de division - chaîne d'approvisionnement en produits nutritionnels chez Abbott Laboratories. Il est titulaire d'un MBA de l'Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBVIE, INC.
0,01% | 29/02/2024 | 98 645 ( 0,01% ) | 17 M $ | 30/04/2024 |
Postes actifs de Robert Michael
| Sociétés | Poste | Début |
|---|---|---|
| ABBVIE INC. | President | 23/06/2022 |
| ALLERGAN PLC | President | 08/05/2020 |
| TOBIRA THERAPEUTICS INC | Directeur Général | - |
AbbVie Biotherapeutics Ltd.
 AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Directeur/Membre du Conseil | 01/04/2019 |
Fremont Holding LLC
 Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Directeur Général | - |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | President | - |
AbbVie Ltd. (United Kingdom)
 AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | President | 01/01/2022 |
Anciens postes connus de Robert Michael
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/2012 |
Formation de Robert Michael
| Kelley School of Business | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 6 |
|---|---|
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Finance |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Commercial Services |
